Trials / Completed
CompletedNCT00366483
Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of Lecozotan SR Administered Orally to Healthy Young and Elderly Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To assess the safety, tolerability and pharmacokinetics of single and multiple ascending oral doses of lecozotan SR in healthy young and elderly subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lecozotan SR |
Timeline
- Start date
- 2006-05-01
- First posted
- 2006-08-21
- Last updated
- 2007-03-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00366483. Inclusion in this directory is not an endorsement.